Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 4, Pages 89
Publisher
MDPI AG
Online
2018-03-22
DOI
10.3390/cancers10040089
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells
- (2017) A.E. Greijer et al. JOURNAL OF VIROLOGICAL METHODS
- Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes
- (2016) Chung-Chun Wu et al. ANTIVIRAL RESEARCH
- Epstein–Barr virus latency type and spontaneous reactivation predict lytic induction levels
- (2016) An T. Phan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cordycepin enhances Epstein–Barr virus lytic infection and Epstein–Barr virus-positive tumor treatment efficacy by doxorubicin
- (2016) Yinping Du et al. CANCER LETTERS
- Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin
- (2016) Octavia Ramayanti et al. INTERNATIONAL JOURNAL OF CANCER
- A novel curcuminoid exhibits enhanced antitumor activity in nasopharyngeal carcinoma
- (2016) YUNBAO PAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Curcumin Enhances the Effects of 5-Fluorouracil and Oxaliplatin in Inducing Gastric Cancer Cell Apoptosis Both In Vitro and In Vivo
- (2016) Xiang Zhou et al. ONCOLOGY RESEARCH
- Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers
- (2016) Deilson Elgui de Oliveira et al. TRENDS IN MICROBIOLOGY
- EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells
- (2016) Peng Zou et al. Oncotarget
- Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
- (2015) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Epstein–Barr virus-targeted therapy in nasopharyngeal carcinoma
- (2015) Sharon D. Stoker et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Genipin as a novel chemical activator of EBV lytic cycle
- (2015) Myoungki Son et al. JOURNAL OF MICROBIOLOGY
- Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations
- (2015) Hiroyuki Abe et al. PATHOBIOLOGY
- Unexpected patterns of Epstein–Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA
- (2015) Rosemary J Tierney et al. VIROLOGY
- Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies
- (2015) Chung King Choi et al. PLoS One
- Curcumin and its Analogues (PGV-0 and PGV-1) Enhance Sensitivity of Resistant MCF-7 Cells to Doxorubicin through Inhibition of HER2 and NF-kB Activation
- (2014) Edy Meiyanto et al. Asian Pacific Journal of Cancer Prevention
- Synthesis and Evaluation of Bisbenzylidenedioxotetrahydrothiopranones as Activators of Endoplasmic Reticulum (ER) Stress Signaling Pathways and Apoptotic Cell Death in Acute Promyelocytic Leukemic Cells
- (2014) Kheng-Lin Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of ATM in the Formation of the Replication Compartment during Lytic Replication of Epstein-Barr Virus in Nasopharyngeal Epithelial Cells
- (2014) Pok Man Hau et al. JOURNAL OF VIROLOGY
- Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
- (2014) Susanna Hilda Hutajulu et al. Therapeutics and Clinical Risk Management
- Identification of a New Class of Small Molecules That Efficiently Reactivate Latent Epstein–Barr Virus
- (2013) Nadezhda Tikhmyanova et al. ACS Chemical Biology
- hTERT Inhibition Triggers Epstein-Barr Virus Lytic Cycle and Apoptosis in Immortalized and Transformed B Cells: A Basis for New Therapies
- (2013) S. Giunco et al. CLINICAL CANCER RESEARCH
- Epstein-Barr Virus-Encoded BARF1 Promotes Proliferation of Gastric Carcinoma Cells through Regulation of NF- B
- (2013) M. S. Chang et al. JOURNAL OF VIROLOGY
- Activation of Human Herpesvirus Replication by Apoptosis
- (2013) A. Prasad et al. JOURNAL OF VIROLOGY
- Efficacy of Low-Dose Oral Metronomic Dosing of the Prodrug of Gemcitabine, LY2334737, in Human Tumor Xenografts
- (2013) S. E. Pratt et al. MOLECULAR CANCER THERAPEUTICS
- Primary Treatment Results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia
- (2013) Maarten A. Wildeman et al. PLoS One
- The Curcumin Analog EF24 Targets NF-κB and miRNA-21, and Has Potent Anticancer Activity In Vitro and In Vivo
- (2013) Chuan He Yang et al. PLoS One
- Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt’s lymphoma cells by affecting multiple molecular targets
- (2012) Alessandra De Leo et al. ANTIVIRAL RESEARCH
- In vitro and in vivo studies of pharmacokinetics and antitumor efficacy of D07001-F4, an oral gemcitabine formulation
- (2012) Wei-Hua Hao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curcumin Analogues with Potent and Selective Anti-proliferative Activity on Acute Promyelocytic Leukemia: Involvement of Accumulated Misfolded Nuclear Receptor Co-repressor (N-CoR) Protein as a Basis for Selective Activity
- (2012) Kheng-Lin Tan et al. ChemMedChem
- Cytolytic Virus Activation Therapy for Epstein-Barr Virus-Driven Tumors
- (2012) M. A. Wildeman et al. CLINICAL CANCER RESEARCH
- Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma
- (2012) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Functions of the Epstein-Barr Virus EBNA1 Protein in Viral Reactivation and Lytic Infection
- (2012) N. Sivachandran et al. JOURNAL OF VIROLOGY
- Inhibition of epstein-barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane
- (2012) Chung-Chun Wu et al. MOLECULAR CARCINOGENESIS
- Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
- (2011) Reason Wilken et al. Molecular Cancer
- Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death
- (2009) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- NF-κB inhibitors induce lytic cytotoxicity in Epstein–Barr virus-positive nasopharyngeal carcinoma cells
- (2008) S LIU et al. CELL BIOLOGY INTERNATIONAL
- Curcumin: From ancient medicine to current clinical trials
- (2008) H. Hatcher et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Epstein-Barr Virus LF2 Protein Inhibits Viral Replication
- (2008) M. A. Calderwood et al. JOURNAL OF VIROLOGY
- Inhibition of I B Kinase-Nuclear Factor- B Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin
- (2008) A. L. Kasinski et al. MOLECULAR PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now